Imidazolium salt (DBZIM) reduces gliosis in mice treated with neurotoxicant 2'-CH(3) -MPTP.
We have recently identified a class of imidazolium salts (IMSs) with antioxidative property and can function as scavengers for radical oxygen species (ROS) [18]. Here, we investigate one of the IMSs, 1,3-bisbenzylimidazolium bromide (DBZIM), for its possible role in attenuating neurotoxicity and gliosis in the retina and the brain induced by a Parkinsonian neurtoxicant, methyl-4(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-CH(3) -MPTP), which is a free radical generating agent. In this study, we employ a molecular retinal imaging method, which we recently developed in a transgenic mouse model expressing green fluorescent protein (GFP) under the control of glial fibrillary acidic protein (GFAP) promoter [14], to assess the efficacy of DBZIM, since currently no in vitro system with a sufficient complexity is available for accurately assessing a compound's efficacy. The longitudinal imaging results showed DBZIM can effectively suppress the neurotoxicant-induced retinal gliosis. Immunohistochemistry performed on the postmodern mouse brain confirmed that DBZIM also reduced striatal gliosis, and concomitantly attenuated the loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc). These findings suggest that DBZIM could be a useful small molecular compound for studying neurotoxicity and neuroprotection in the retina and the brain.
Ho
Gideon
G
Institute of Bioengineering and Nanotechnology, Singapore.
Kumar
Saravana
S
Ke
Zhiyuan
Z
Chan
Hugh Hiu Nam
HH
Suhaimi
Nur-Afidah Mohamed
NA
Kng
Yin Ling
YL
Zhang
Yugen
Y
Zhuo
Lang
L
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000031:analogs & derivatives*; D000818:Animals; D001921:Brain / Q000473:pathology; D004298:Dopamine / Q000502:physiology; D018492:Dopamine Antagonists / Q000633:toxicity*; D005123:Eye / Q000473:pathology; D005904:Glial Fibrillary Acidic Protein / Q000235:genetics; D005911:Gliosis / Q000139:chemically induced* / Q000473:pathology / Q000517:prevention & control*; D049452:Green Fluorescent Proteins; D007093:Imidazoles / Q000494:pharmacology*; D007150:Immunohistochemistry; D020287:In Situ Nick-End Labeling; D020267:MPTP Poisoning / Q000473:pathology / Q000517:prevention & control*; D051379:Mice; D008822:Mice, Transgenic; D017072:Neostriatum / Q000201:enzymology; D009474:Neurons / Q000473:pathology; D009887:Ophthalmoscopy; D012160:Retina / Q000473:pathology; D013482:Superoxide Dismutase / Q000378:metabolism
C560871:1,3-bisbenzylimidazolium; D018492:Dopamine Antagonists; D005904:Glial Fibrillary Acidic Protein; D007093:Imidazoles; C048977:1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine; D049452:Green Fluorescent Proteins; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D013482:Superoxide Dismutase; D004298:Dopamine
Neurobiol Dis. 2006 Jul;23(1):77-86
16545572
Biomed Environ Sci. 1991 Jun;4(1-2):197-206
1910596
Parkinsonism Relat Disord. 2005 Jun;11 Suppl 1:S9-S15
15885630
CNS Drugs. 2005;19(9):723-43
16142989
Neurotoxicology. 2002 Sep;23(3):367-74
12387363
J Biol Chem. 2005 Aug 12;280(32):29194-8
15946937
J Biochem Mol Toxicol. 2005;19(1):32-41
15736157
Neurosci Lett. 1994 Oct 24;180(2):147-50
7700568
Vision Res. 2005 Dec;45(28):3512-9
16188288
J Neurochem. 2001 Mar;76(5):1265-74
11238711
Neuron. 2003 Sep 11;39(6):889-909
12971891
Exp Eye Res. 1985 Apr;40(4):509-19
2988989
Nat Neurosci. 2000 Sep;3(9):873-80
10966617
Acta Physiol Scand. 1965 May-Jun;64:58-66
14348505
Drugs Aging. 1999 Feb;14(2):115-40
10084365
Dev Biol. 1997 Jul 1;187(1):36-42
9224672
Neurochem Res. 2003 Jun;28(6):805-14
12718432
NeuroRx. 2005 Jul;2(3):484-94
16389312
Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):251-6
15979668
J Neurochem. 2001 Jul;78(1):1-12
11432968
Glia. 2005 Nov 1;52(2):144-52
15920722
Trends Neurosci. 1990 Jul;13(7):296-302
1695407
Opt Express. 2008 May 26;16(11):8250-62
18545537
J Neurochem. 2001 Sep;78(5):1073-82
11553681
J Comp Neurol. 2005 Dec 12;493(2):261-73
16255027
Science. 1978 Nov 24;202(4370):901-2
30997
Hum Mol Genet. 2002 Dec 15;11(26):3351-9
12471061
Neurosci Lett. 1986 Dec 12;72(2):221-6
3492691
Neurotoxicol Teratol. 1988 Sep-Oct;10(5):445-52
3247001
J Am Chem Soc. 2008 Sep 24;130(38):12586-7
18761448
Annu Rev Neurosci. 1999;22:123-44
10202534
Invest Ophthalmol Vis Sci. 2009 May;50(5):2459-64
19151398